- 全部删除
您的购物车当前为空
FTIDC 是非竞争性和选择性的口服变构代谢型谷氨酸受体 1 拮抗剂,对人 mGluR1a 的IC50为 5.8 nM。


为众多的药物研发团队赋能,
让新药发现更简单!
FTIDC 是非竞争性和选择性的口服变构代谢型谷氨酸受体 1 拮抗剂,对人 mGluR1a 的IC50为 5.8 nM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 917 | In stock | |
| 2 mg | ¥ 1,370 | In stock | |
| 5 mg | ¥ 2,360 | In stock | |
| 10 mg | ¥ 3,770 | In stock | |
| 25 mg | ¥ 5,930 | In stock | |
| 50 mg | ¥ 8,190 | In stock | |
| 100 mg | ¥ 10,800 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,530 | In stock |
FTIDC 相关产品
| 产品描述 | FTIDC is a highly potent and selective allosteric antagonist of mGluR1 receptors and shows very weak potency against human and rat mGluR5 receptors. The inhibition of FTIDC for mGluR1 receptors is shown to be in noncompetitive manner and displays IC50 values of 5.8 and 3.1 nM for human and mouse mGluR1 expressed in CHO cells respectively. |
| 靶点活性 | mGluR1(mouse):3.1 nM, mGluR1(human):5.8 nM, mGlu5:6200 nM |
| 分子量 | 358.41 |
| 分子式 | C18H23FN6O |
| CAS No. | 873551-53-2 |
| Smiles | CC(C)N(C)C(=O)N1CCC(=CC1)c1nnn(c1C)-c1cccnc1F |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 35.8 mg/mL (99.89 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.58 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容